Is multiple sclerosis a risk factor for atherosclerosis?

Karabudak, 2015, Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Turkey, J Med Econ, 18, 69, 10.3111/13696998.2014.950420

Brønnum-Hansen, 2004, Trends in survival and cause of death in Danish patients with multiple sclerosis, Brain, 127, 844, 10.1093/brain/awh104

Marrie, 2009, Comorbidity delays diagnosis and increases disability at diagnosis in MS, Neurology, 72, 117, 10.1212/01.wnl.0000333252.78173.5f

Marrie, 2015, Effect of comorbidity on mortality in multiple sclerosis, Neurology, 85, 240, 10.1212/WNL.0000000000001718

Krokki, 2014, Neurological comorbidity and survival in multiple sclerosis, Mult Scler Relat Disord, 3, 72, 10.1016/j.msard.2013.06.006

Marrie, 2010, Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis, Neurology, 74, 1041, 10.1212/WNL.0b013e3181d6b125

Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353

Kuller, 2000, The role of inflammation in cardiovascular disease, Arterioscler Thromb Vasc Biol, 20, 901, 10.1161/01.ATV.20.4.901

Balla, 2006, Serum levels of platelet released CD40 ligand are increased in early onset occlusive carotid artery disease, Dis Markers, 22, 133, 10.1155/2006/427174

Davidson, 2014, Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST), Arterioscler Thromb Vasc Biol, 34, 1298, 10.1161/ATVBAHA.113.302926

Chen, 2018, Carotid thickness and atherosclerotic plaque stability, serum inflammation, serum MMP-2 and MMP-9 were associated with acute cerebral infarction, Exp Ther Med, 16, 5253

Timóteo, 2018, Has carotid intima-media thickness prognostic impact in patients with high cardiovascular risk? A long-term cohort study, Echocardiography.

Tillet, 1930, Serological reactions in pneumonia with a non-protein fraction from pneumococcus, J Exp Med, 52, 561, 10.1084/jem.52.4.561

Patgiri, 2014, Serum hs-CRP: a novel marker for prediction of cerebrovascular accidents (stroke), J Clin Diagn Res, 8

Blake, 2003, Blood pressure, C-reactive protein, and risk of future cardiovascular events, Circulation, 108, 2993, 10.1161/01.CIR.0000104566.10178.AF

Tanne, 2006, C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease, Stroke, 37, 1720, 10.1161/01.STR.0000227004.08182.bf

Stone, 2014, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation, 129, 10.1161/01.cir.0000437738.63853.7a

Di Napoli, 2011, Role of C-reactive protein in cerebrovascular disease, Expert Rev Cardiovasc Ther, 9, 1565, 10.1586/erc.11.159

Wakugawa, 2006, C-reactive protein and risk of first-ever ischaemic and haemorrhagic stroke in a general Japanese population–The Hisayama study, Stroke, 37, 27, 10.1161/01.STR.0000194958.88216.87

Andersson, 2009, C-reactive protein is a determinant of first-ever stroke: prospective nested cross-referent study, Cerebrovasc Dis, 27, 544, 10.1159/000214217

Christiansen, 2012, Risk of vascular disease in patients with multiple sclerosis: a review, Neurol Res, 34, 746, 10.1179/1743132812Y.0000000051

Ranadive, 2012, Vascular dysfunction and physical activity in multiple sclerosis, Med Sci Sports Exerc, 44, 238, 10.1249/MSS.0b013e31822d7997

Faul, 2007, G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences, Behav Res Methods, 39, 175, 10.3758/BF03193146

D’haeseleer, 2011, Vascular aspects of multiple sclerosis, Lancet Neurol, 10, 657, 10.1016/S1474-4422(11)70105-3

Christiansen, 2010, Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study, Neuroepidemiology, 35, 267, 10.1159/000320245

Allen, 2008, Vascular disease among hospitalized multiple sclerosis patients, Neuroepidemiology, 30, 234, 10.1159/000128103

Fleming, 1994, Patterns of comorbidity in elderly patients with multiple sclerosis, J Clin Epidemiol, 47, 1127, 10.1016/0895-4356(94)90099-X

Hirst, 2008, Survival and cause of death in multiple sclerosis: a population-based cohort study, J Neurol Neurosurg Psychiatry, 79, 1016, 10.1136/jnnp.2007.127332

Sadovnick, 1991, Cause of death in patients attending multiple sclerosis clinics, Neurology, 41, 1193, 10.1212/WNL.41.8.1193

Oren, 2003, Change in body mass index from adolescence to young adulthood and increased carotid intima-media thickness at 28 years of age: the Atherosclerosis Risk in Young Adults study, Int J Obes Relat Metab Disord, 27, 1383, 10.1038/sj.ijo.0802404

Stensland-Bugge, 2001, Age and sex differences in the relationship between inherited and lifestyle risk factors and subclinical carotid atherosclerosis: the Tromso study, Atherosclerosis, 154, 437, 10.1016/S0021-9150(00)00486-X

Hernandez, 2003, Is there a side predilection for cerebrovascular disease?, Hypertension, 42, 56, 10.1161/01.HYP.0000077983.66161.6F

Luo, 2011, Differences in left and right carotid intima-media thickness and the associated risk factors, Clin Radiol, 66, 393, 10.1016/j.crad.2010.12.002

Georgiopoulos, 2009, Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors, Hypertension, 54, 98e105, 10.1161/HYPERTENSIONAHA.109.132100

Muscelli, 2009, The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women, Am J Hypertens, 22, 364e70, 10.1038/ajh.2009.16

Perticone, 2001, Prognostic significance of endothelial dysfunction in hypertensive patients, Circulation, 104, 191e6, 10.1161/01.CIR.104.2.191

Vikan, 2009, Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Troms study, Eur J Epidemiol, 24, 10.1007/s10654-009-9322-2

Pasceri, 2000, Direct proinflammatory effect of C-reactive protein on human endothelial cells, Circulation, 102, 2165, 10.1161/01.CIR.102.18.2165

Giovanni, 2001, Serum inflammatory markers and clinical/MRI marker of disease progression in multiple sclerosis, J Neurol, 248, 487, 10.1007/s004150170158

Fjeldstad, 2011, Vascular function and multiple sclerosis, J Neurol, 258, 2036, 10.1007/s00415-011-6065-2

Wang, 2002, Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study, Arterioscler Thromb Vasc Biol, 22, 1662, 10.1161/01.ATV.0000034543.78801.69

Niino, 2015, Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis, Can J Physiol Pharmacol, 93, 319, 10.1139/cjpp-2014-0374

Oliveira, 2017, deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress, J Neurol Sci, 381, 213, 10.1016/j.jns.2017.07.046

Becker, 2016, Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil, J Neurol Sci, 363, 236, 10.1016/j.jns.2016.02.064

Pierrot-Deseilligny, 2013, Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis, Ther Adv Neurol Disord, 6, 81, 10.1177/1756285612473513